DBV Technologies sells $30 million of shares through ATM program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025 5:02 PM EDTChâtillon, France, October 6, 2025
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies (Euronext: DBV ISIN: FR0010417345 Nasdaq Capital Market: DBVT) (the Company), a clinical-stage biopharmaceutical company, today announced that, pursuant to the Companys At-The-Market program established on September 5, 2025 (the ATM Program), it has agreed to issue and sell new ordinary shares (the Ordinary Shares) in the form of American Depositary Shares (ADSs), for total gross proceeds to the Company of approximately $30 million, before deducting sales agent commissions... More



